ChinaDaily Briefs

Daily Brief China: Beijing Strong Biotechnolo-A, United Nova Technology , Bank of Communications , Shenzhen New Industries Biomedical Engineering-A, China Traditional Chinese Medicine, Biwin Storage Technology Lt, Yunnan Aluminium Co Ltd A, SHEIN, Shanghai Fosun Pharmaceutical (Group), Guosen Securities and more

In today’s briefing:

  • CSI Medical Service Index Rebalance: Adds Could Outperform Deletes in the Coming Week
  • STAR50/STAR100 Index Rebalance: Index Committee Flip-Flops on Profitability
  • SSE50/SSE180 Index Rebalance: Heavy Focus on Sector Balance
  • Quiddity CSI 300/​​500 Jun 24 Rebalance: 92% Hit Rate; US$3.7 One-Way Flows
  • Merger Arb Mondays (03 Jun) – China TCM, Huafa, GA Pack, SciClone, CF Logistics, Great Eastern
  • CES China Semiconductor Chips Index Rebalance: Adding to Impact for Some Stocks
  • CSI300/CSI500 Index Rebalance: Big Flows and US$5bn Round-Trip Trade
  • SHEIN: Several US Customs Broker Suspensions Tied to Tighter ‘de Minimis’ Rules
  • Fosun Pharma (2196 HK/600196.CH) To Privatize Henlius (2696.HK) – Things Are Not as Good as Expected
  • CSI All Share IB & Brokerage Index Rebalance: Couple of Large Flow & Impact Names


CSI Medical Service Index Rebalance: Adds Could Outperform Deletes in the Coming Week

By Brian Freitas

  • CSI announced the changes for the June rebalance after market close on 31 May and the changes will be effective after the close of trading on 14 June.
  • There are 5 adds/deletes – we correctly forecasted 3 adds and all 5 deletes. Passives need to trade 0.5-3x ADV on the adds and 0.5-2.1x ADV on the deletes.
  • With the index not very widely forecasted, the adds could outperform the deletes over the next week in a repeat of the performance at the December rebalance.

STAR50/STAR100 Index Rebalance: Index Committee Flip-Flops on Profitability

By Brian Freitas


SSE50/SSE180 Index Rebalance: Heavy Focus on Sector Balance

By Brian Freitas

  • There are 5 changes for the SSE50 Index (SSE50 INDEX) that will be implemented at the close on 14 June. There is over 1x ADV to trade on most stocks.
  • The index committee has focused on sector balance with higher ranked stocks from the Financials sector ignored and lower ranked stocks from other sectors included.
  • The adds have outperformed the deletes over the last 6 months and positioning (especially on the surprises) could lead to further upside for a long/short trade.

Quiddity CSI 300/​​500 Jun 24 Rebalance: 92% Hit Rate; US$3.7 One-Way Flows

By Janaghan Jeyakumar, CFA

  • The June 2024 index review results for China’s CSI 300 and CSI 500 indices were announced after market close on Friday 31st May 2024.
  • There will be 12 changes in CSI 300 and 50 changes in CSI 500 which could collectively cause one-way index flows of ~US$3.7bn during the June 2024 index rebal event.
  • Compared to Quiddity’s final expectations, 114 out of the 124 index changes (both ways) were correct translating to a hit rate of 92%. 


CES China Semiconductor Chips Index Rebalance: Adding to Impact for Some Stocks

By Brian Freitas

  • There are 4 changes for the CES China Semiconductor Chips Index that will be implemented at the close on 14 June.
  • Biwin Storage Technology Lt (688525 CH) and Beijing Yandong Microelectroni (688172 CH) are also inclusions to other indices too and the multiple flows will increase the impact on the stocks.
  • The adds have underperformed the deletes. If things go the way of the December rebalance, a long adds/ short deletes trade could do well from now to implementation.

CSI300/CSI500 Index Rebalance: Big Flows and US$5bn Round-Trip Trade

By Brian Freitas

  • There are 12 changes for the CSI 300 Index (SHSZ300 INDEX) and 50 changes for the CSI Smallcap 500 Index (SH000905 INDEX) in June. Most changes were expected.
  • There are a lot of stocks with over 1 day of ADV to trade. The round-trip trade in June is estimated to be US$5bn.
  • The adds have outperformed the deletes for both indices but the return profile of a long adds/ short deletes trade for the CSI500 Index is a lot smoother.

SHEIN: Several US Customs Broker Suspensions Tied to Tighter ‘de Minimis’ Rules

By Daniel Hellberg

  • Several US customs brokers have been suspended under new, tighter rules
  • The new rules could make ‘de minimis’ imports slightly more difficult
  • Whether it lists in London or NYC, additional rule changes could threaten SHEIN

Fosun Pharma (2196 HK/600196.CH) To Privatize Henlius (2696.HK) – Things Are Not as Good as Expected

By Xinyao (Criss) Wang

  • It is said that Fosun Pharma plans to privatize Henlius. There’re doubts about how to solve the debt problem/cash flow pressure of Fosun Pharma. A third party could be involved.
  • Shareholders may not be willing to accept an Offer Price that is significantly below IPO price. It’s also possible that shareholders vote against the privatization. So, there are many uncertainties.
  • Deal talks are still ongoing. It’s difficult to see clearly what’s happening under the table. Valuation logic of Fosun Pharma should be more like PE/VC firms not traditional pharmaceutical company.

CSI All Share IB & Brokerage Index Rebalance: Couple of Large Flow & Impact Names

By Brian Freitas

  • The changes to the CSI All Share Investment Banking & Brokerage Index were announced after market close on 31 May and will be implemented at the close on 14 June.
  • Guosen Securities (002736 CH) will be added to the index while Northeast Securities (000686 CH) will be deleted from the index.
  • There is a lot of flow and impact for both stocks and the stocks could outperform/underperform their peers over the next couple of weeks.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars